Back to overview
Guide 8 November 2026 · 5 min read

Botox or Vistabel? What the Brand Name Actually Means

Botox or Vistabel? What the Brand Name Actually Means
Dr. med. Felicitas Mrochen

Medically reviewed by

Dr. med. Felicitas Mrochen

Aesthetic Medicine Physician · Last reviewed: November 2026

"I'd like Botox." We hear that sentence in the practice almost daily, and it is usually not quite accurate: what's meant is generally a muscle relaxant treatment, not necessarily the specific product that is actually named "Botox" on the vial. The term has become a generic label, similar to how "Kleenex" stands for tissues generally. Linguistically interesting, medically imprecise.

Botulinum toxin type A: one active ingredient, several brand names

Botulinum toxin type A is the active ingredient. Several manufacturers bring it to market under different brand names, each with its own approval:

  • Botox® (Allergan/AbbVie): approved in Germany for medical indications such as chronic migraine and primary axillary hyperhidrosis – not for aesthetic wrinkle treatment. Efficacy for both indications has been studied in large controlled trials[2][3].
  • Vistabel® (Allergan/AbbVie, same active ingredient as Botox®): the sister brand from the same manufacturer, approved for aesthetic treatment of frown lines, crow's feet, and forehead lines.
  • Bocouture® (Merz): incobotulinumtoxinA, also approved for the same three aesthetic indications.
  • Azzalure® (Galderma): abobotulinumtoxinA, approved for frown lines and crow's feet.

The active substances are related but not identical: onabotulinumtoxinA (Botox/Vistabel), incobotulinumtoxinA (Bocouture), and abobotulinumtoxinA (Azzalure) differ in manufacturing and dosing units. One unit of one product does not automatically equal one unit of another.

Why we say "muscle relaxant treatment"

At minimal med, we use Botox® specifically for migraine and primary hyperhidrosis, because this product is approved precisely for those indications in Germany. For classic aesthetic wrinkle treatment, we use an approved product from the same active-ingredient class. On our treatment pages, we usually say "muscle relaxant treatment" rather than simply "Botox," for two reasons: first, "Botox" is a legally protected brand name that, strictly speaking, refers to only one of several products. Second, we want to inform factually about the procedure, not advertise with a brand name.

That changes nothing about what actually happens medically: the active ingredient relaxes targeted overactive muscles, whether you call it "Botox," "muscle relaxant," or by its scientific name, botulinum toxin type A.

Where does the active ingredient actually come from?

Botulinum toxin was not originally developed for wrinkles at all. It was first used medically to treat strabismus (crossed eyes)[1]. It was only later, through related neurological applications around the eye area, that doctors noticed patients also happened to get smoother frown lines as a side effect. The aesthetic application is, in that sense, an accidental spin-off of an originally neurological therapy.

Common mix-ups

"Is Botox the same as hyaluronic acid?" No. Botulinum toxin relaxes muscles and works against expression-driven wrinkles. Hyaluronic acid adds volume and works against static wrinkles caused by volume loss. The two are often combined, but they work on different principles.

"Is more Botox always better?" No. Dosage determines the result. Too high a dose leads to the "frozen" look most patients specifically want to avoid. More on this in our article on the most common wrinkle-treatment myths.

Bottom line

In everyday language, "Botox" has become the catch-all term for an entire treatment class, but it technically refers to only one of several products, each with its own approval. In practice, this rarely matters much for the patient: what matters is the treating physician's experience, correct dosing, and the product actually used, not the brand name people use to describe it.

References

  1. [1] Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734-770. PubMed: 7043871
  2. [2] Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ. 2001;323(7313):596-599. PubMed: 11557704
  3. [3] Diener HC, Dodick DW, Aurora SK et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the PREEMPT 2 trial. Cephalalgia. 2010;30(7):804-814. PubMed: 20647171

Last reviewed: November 2026. This article does not replace medical advice. Approval information per manufacturer prescribing information (fachinfo.de), as of September 2025 – always check current prescribing information if in doubt.

Dr. Felicitas Mrochen

Dr. Felicitas Mrochen

Aesthetic Medicine Physician in Munich

Have questions about this topic?

Your questions are gladly answered in a personal consultation.

More Articles